Thomas Wessel, Chief Medical Officer at Flex Pharma, Inc. (FLKS), bought 20,000 shares at $9.13 ($159K) on 2016-03-14, disclosed to the SEC on 2016-03-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.15 | 12,000 | $86K | 54.0% |
| 2 | $9.13 | 8,000 | $73K | 46.0% |
| Total | $7.94 avg | 20,000 | $159K | 100% |
| Filing → |
| ADI | SELL | 2013-09-20 | $86K | — | Filing → |
| ADI | SELL | 2012-12-20 | $687K | — | Filing → |